Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ansell
Claire Ansell, Chester GB
| Patent application number | Description | Published |
|---|---|---|
| 20080244966 | FUEL COMPOSITIONS - Use of a Fischer-Tropsch derived fuel component, in a fuel composition, is provided reducing the tendency of the composition to dissolve metals; increasing its thermal stability; reducing the concentration of a metal deactivator, antioxidant or detergent additive in the composition; or increasing the storage stability of the composition. The composition is preferably a diesel fuel composition. | 10-09-2008 |
Claire Ansell, Cheshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20090093658 | Process to Blend a Mineral and a Fischer-Tropsch Derived Product Onboard a Marine Vessel - Process to blend a mineral derived hydrocarbon product and a Fischer-Tropsch derived hydrocarbon product by providing in a storage vessel of a marine vessel a quantity of mineral derived hydrocarbon product and Fischer-Tropsch derived hydrocarbon product such that initially the mineral derived hydrocarbon product is located substantially above the Fischer-Tropsch derived hydrocarbon product, transporting the combined products in the marine vessel from one location to another location, also referred to as the destination, and obtaining a blended product at arrival of the marine vessel at its destination. | 04-09-2009 |
| 20110284117 | FUEL COMPOSITIONS - A system comprising a liner at an interior of the pipe; at least one dry fiber tri-axial braid layer exterior to the liner, the tri-axial braid layer comprising a plurality of axial fibers, a plurality of clockwise fibers, and a plurality of counterclockwise fibers. | 11-24-2011 |
Iain Ansell, Suffolk GB
| Patent application number | Description | Published |
|---|---|---|
| 20110319719 | THORACIC ACCESS PORT - A surgical access assembly having a body including a leading end, a trailing end, and first and second body members extending between the leading and trailing ends. The leading end, trailing end and first and second body members define a passageway therethrough for receipt of surgical instrumentation. First and second flexible wing members extend proximally from the body. A flexible member is attached to the body and extends proximally therefrom. | 12-29-2011 |
Iain Ansell, Newmarket GB
| Patent application number | Description | Published |
|---|---|---|
| 20110190780 | SURGICAL RETRIEVAL APPARATUS - A method of retrieving a tissue specimen comprising inserting a surgical retrieval apparatus through an opening in a patient's skin, the surgical retrieval apparatus including a support member and a retrieval bag extending from the support member and having an opening to receive the tissue specimen. A net is introduced into the retrieval bag and placed over the tissue specimen. The net and retrieval bag are removed from the patient's body to remove the tissue specimen. | 08-04-2011 |
Jayne Ansell, Loxwood GB
| Patent application number | Description | Published |
|---|---|---|
| 20110092455 | Method and Composition for the Control of Arthropods - The present invention relates to the use of certain siloxanes and mixtures thereof in the control of arthropods such as insects and arachnids, and in particular ectoparasites, such as head lice. | 04-21-2011 |
Keith H. Ansell, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20090156457 | METHODS AND MEANS FOR SCREENING FOR RHOMBOID ACTIVITY - This invention relates to methods of screening for rhomboid modulating compounds using a substrate polypeptide has a core domain comprising a rhomboid cleavable TMD sequence linked to an upstream tag sequence. The core domain sequence is not susceptible to cleavage by non-rhomboid proteases so products of rhomboid dependent proteolysis products may be detected by determining the presence of the tag sequence. Rhomboid modulating compounds identified by the present methods may be useful in a range of therapeutic applications. | 06-18-2009 |
Oliver Ansell, Berkeley GB
| Patent application number | Description | Published |
|---|---|---|
| 20100230049 | APPARATUS FOR CHEMICALLY ETCHING A WORKPIECE - Apparatus for chemically etching a workpiece includes a chamber for receiving a process gas and having a pumping port for extracting exhaust gases, and a workpiece support located in the chamber upstream of the pumping port. The chamber further includes a sub-chamber located upstream of the pumping port and downstream of the workpiece support, and the sub-chamber includes a window and an excitation source, adjacent the window, for creating a plasma in a sample of the exhaust gases to create an optical emission which can be monitored through the window. | 09-16-2010 |
Peter John Ansell, Watford GB
| Patent application number | Description | Published |
|---|---|---|
| 20120131513 | Gesture Recognition Training - Gesture recognition training is described. In an example, a gesture recognizer is trained to detect gestures performed by a user on an input device. Example gesture records, each showing data describing movement of a finger on the input device when performing an identified gesture are retrieved. A parameter set that defines spatial triggers used to detect gestures from data describing movement on the input device is also retrieved. A processor determines a value for each parameter in the parameter set by selecting a number of trial values, applying the example gesture records to the gesture recognizer with each trial value to determine a score for each trial value, using the score for each trial value to estimate a range of values over which the score is a maximum, and selecting the value from the range of values. | 05-24-2012 |
| 20120131514 | Gesture Recognition - Gesture recognition is described. In one example, gestures performed by a user of an input device having a touch-sensitive portion are detected using a definition of a number of regions corresponding to zones on the touch-sensitive portion, each region being associated with a distinct set of gestures. Data describing movement of the user's digits on the touch-sensitive portion is received, and an associated region for the data determined. The data is compared to the associated region's set of gestures, and a gesture applicable to the data selected. A command associated with the selected gesture can then be executed. In an example, comparing the data to the set of gestures comprises positioning a threshold for each gesture relative to the start of the digit's movement. The digit's location is compared to each threshold to determine whether a threshold has been crossed, and, if so, selecting the gesture associated with that threshold. | 05-24-2012 |
Steven M. Ansell, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20080200417 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES - Methods for the preparation of a lipid-nucleic acid composition are provided. According to the methods, a mixture of lipids containing a protonatable or deprotonatable lipid, for example an amino lipid and a lipid such as a PEG- or Polyamide oligomer-modified lipid is combined with a buffered aqueous solution of a charged therapeutic agent, for example polyanionic nucleic acids, to produce particles in which the therapeutic agent is encapsulated in a lipid vesicle. Surface charges on the lipid particles are at least partially neutralized to provide surface-neutralized lipid-encapsulated compositions of the therapeutic agents. The method permits the preparation of compositions with high ratios of therapeutic agent to lipid and with encapsulation efficiencies in excess of 50%. | 08-21-2008 |
| 20120114831 | HIGH EFFICIENCY ENCAPSULATION OF CHARGED THERAPEUTIC AGENTS IN LIPID VESICLES - Methods for the preparation of a lipid-nucleic acid composition are provided. According to the methods, a mixture of lipids containing a protonatable or deprotonatable lipid, for example an amino lipid and a lipid such as a PEG- or Polyamide oligomer-modified lipid is combined with a buffered aqueous solution of a charged therapeutic agent, for example polyanionic nucleic acids, to produce particles in which the therapeutic agent is encapsulated in a lipid vesicle. Surface charges on the lipid particles are at least partially neutralized to provide surface-neutralized lipid-encapsulated compositions of the therapeutic agents. The method permits the preparation of compositions with high ratios of therapeutic agent to lipid and with encapsulation efficiencies in excess of 50%. | 05-10-2012 |